Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 37

1.

Human Immunodeficiency Virus (HIV) Positive Case with Squamous Cell Larynx Cancer: Difficulties in the Choice of Treatment.

Ünsal Ö, Türk B, Akpınar M, Bağlı M, Coşkun BU.

Turk Arch Otorhinolaryngol. 2015 Sep;53(3):136-138. doi: 10.5152/tao.2015.839. Epub 2015 Sep 1.

2.

Pharmacokinetics of m-chlorophenylpiperazine after intravenous and oral administration in healthy male volunteers: implication for the pharmacodynamic profile.

Feuchtl A, Bagli M, Stephan R, Frahnert C, Kölsch H, Kühn KU, Rao ML.

Pharmacopsychiatry. 2004 Jul;37(4):180-8.

PMID:
15467976
3.

CYP2D6 polymorphism and tardive dyskinesia in schizophrenic patients.

Lohmann PL, Bagli M, Krauss H, Müller DJ, Schulze TG, Fangerau H, Ludwig M, Barkow K, Held T, Heun R, Maier W, Rietschel M, Rao ML.

Pharmacopsychiatry. 2003 Mar-Apr;36(2):73-8.

PMID:
12734765
4.

Polymorphisms of the gene encoding the inflammatory cytokine interleukin-6 determine the magnitude of the increase in soluble interleukin-6 receptor levels in Alzheimer's disease. Results of a pilot study.

Bagli M, Papassotiropoulos A, Hampel H, Becker K, Jessen F, Bürger K, Ptok U, Rao ML, Möller HJ, Maier W, Heun R.

Eur Arch Psychiatry Clin Neurosci. 2003 Feb;253(1):44-8.

PMID:
12664314
5.

Allelic variants of the serotonin(2C) receptor and neuroendocrinological responses to the serotonin(2C) receptor agonist m-chlorophenylpiperazine in healthy male volunteers.

Kühn KU, Quednow BB, Bagli M, Meyer K, Feuchtl A, Westheide J, Frahnert C, Maier W, Rao ML.

Pharmacopsychiatry. 2002 Nov;35(6):226-30.

PMID:
12518270
6.

Cerebrospinal fluid levels of beta-amyloid(42) in patients with Alzheimer's disease are related to the exon 2 polymorphism of the cathepsin D gene.

Papassotiropoulos A, Lewis HD, Bagli M, Jessen F, Ptok U, Schulte A, Shearman MS, Heun R.

Neuroreport. 2002 Jul 19;13(10):1291-4.

PMID:
12151789
7.

The insulin gene VNTR polymorphism in Alzheimer's disease: results of a pilot study.

Majores M, Kölsch H, Bagli M, Ptok U, Kockler M, Becker K, Rao ML, Maier W, Heun R.

J Neural Transm (Vienna). 2002 Jul;109(7-8):1029-34.

PMID:
12111440
8.

Cathepsin D: screening for new polymorphisms using single-strand conformation polymorphism analysis.

Majores M, Kolsch H, Bagli M, Papassotiropoulos A, Lohmann PL, Schmitz S, Rao ML, Maier W, Heun R.

Int J Mol Med. 2002 Feb;9(2):185-7.

PMID:
11786931
9.

24S-hydroxycholesterol in cerebrospinal fluid is elevated in early stages of dementia.

Papassotiropoulos A, Lütjohann D, Bagli M, Locatelli S, Jessen F, Buschfort R, Ptok U, Björkhem I, von Bergmann K, Heun R.

J Psychiatr Res. 2002 Jan-Feb;36(1):27-32.

PMID:
11755458
10.

Influence of CYP2D6 genotype and medication on the sparteine metabolic ratio of psychiatric patients.

Lohmann PL, Rao ML, Ludwig M, Griese EU, Zanger UM, Mörike K, Maier W, Bagli M.

Eur J Clin Pharmacol. 2001 Jul;57(4):289-95. Erratum in: Eur J Clin Pharmacol 2001 Dec;57(10):745.

PMID:
11549206
11.

Serum levels and cardiovascular effects of tricyclic antidepressants and selective serotonin reuptake inhibitors in depressed patients.

Rodriguez de la Torre B, Dreher J, Malevany I, Bagli M, Kolbinger M, Omran H, Lüderitz B, Rao ML.

Ther Drug Monit. 2001 Aug;23(4):435-40.

PMID:
11477329
12.

Gene polymorphisms of interleukin-1alpha influence the course of Alzheimer's disease.

Kölsch H, Ptok U, Bagli M, Papassotiropoulos A, Schmitz S, Barkow K, Kockler M, Rao ML, Maier W, Heun R.

Ann Neurol. 2001 Jun;49(6):818-9. No abstract available.

PMID:
11409442
13.

Identical distribution of the alpha 2-macroglobulin pentanucleotide deletion in subjects with Alzheimer disease and controls in a German population.

Bagli M, Papassotiropoulos A, Jessen F, Schmitz S, Rao ML, Maier W, Heun R.

Am J Med Genet. 2000 Dec 4;96(6):775-7.

PMID:
11121179
14.
15.

No association between an intronic biallelic polymorphism of the FE65 gene and Alzheimer's disease.

Papassotiropoulos A, Bagli M, Becker K, Jessen F, Maier W, Rao ML, Ludwig M, Heun R.

Int J Mol Med. 2000 Nov;6(5):587-9.

PMID:
11029529
16.
17.

Allelic association between the D10S1423 marker and Alzheimer's disease in a German population.

Majores M, Bagli M, Papassotiropoulos A, Schwab SG, Jessen F, Rao ML, Maier W, Heun R.

Neurosci Lett. 2000 Aug 11;289(3):224-6.

PMID:
10961670
18.

Interaction of two genes possibly involved in the regulation of the amyloid precursor protein (APP) processing.

Papassotiropoulos A, Bagli M, Jessen F, Maier W, Förstl H, Kurz A, Heun R.

Mol Psychiatry. 2000 May;5(3):240-1. No abstract available.

19.

Plasma 24S-hydroxycholesterol: a peripheral indicator of neuronal degeneration and potential state marker for Alzheimer's disease.

Papassotiropoulos A, Lütjohann D, Bagli M, Locatelli S, Jessen F, Rao ML, Maier W, Björkhem I, von Bergmann K, Heun R.

Neuroreport. 2000 Jun 26;11(9):1959-62.

PMID:
10884051
20.

Confirmation of the association between bleomycin hydrolase genotype and Alzheimer's disease.

Papassotiropoulos A, Bagli M, Jessen F, Frahnert C, Rao ML, Maier W, Heun R.

Mol Psychiatry. 2000 Mar;5(2):213-5.

21.

Association between an interleukin-6 promoter and 3' flanking region haplotype and reduced Alzheimer's disease risk in a German population.

Bagli M, Papassotiropoulos A, Knapp M, Jessen F, Luise Rao M, Maier W, Heun R.

Neurosci Lett. 2000 Apr 7;283(2):109-12.

PMID:
10739887
22.

A genetic variation of cathepsin D is a major risk factor for Alzheimer's disease.

Papassotiropoulos A, Bagli M, Kurz A, Kornhuber J, Förstl H, Maier W, Pauls J, Lautenschlager N, Heun R.

Ann Neurol. 2000 Mar;47(3):399-403.

PMID:
10716266
23.

Plasma 24S-hydroxycholesterol (cerebrosterol) is increased in Alzheimer and vascular demented patients.

Lütjohann D, Papassotiropoulos A, Björkhem I, Locatelli S, Bagli M, Oehring RD, Schlegel U, Jessen F, Rao ML, von Bergmann K, Heun R.

J Lipid Res. 2000 Feb;41(2):195-8.

24.

Gene-gene interaction between interleukin-6 and alpha2-macroglobulin influences the risk for Alzheimer's disease.

Bagli M, Papassotiropoulos A, Jessen F, Rao ML, Maier W, Heun R.

Ann Neurol. 2000 Jan;47(1):138-9. No abstract available.

PMID:
10632118
25.

Alpha-1-antichymotrypsin gene polymorphism and risk for sporadic Alzheimer's disease in a German population.

Schwab SG, Bagli M, Papassotiropoulos A, Jessen F, Maier W, Rao ML, Heun R.

Dement Geriatr Cogn Disord. 1999 Nov-Dec;10(6):469-72.

PMID:
10559561
26.

Pharmacokinetic-pharmacodynamic modeling of tolerance to the prolactin-secreting effect of chlorprothixene after different modes of drug administration.

Bagli M, Süverkrüp R, Quadflieg R, Höflich G, Kasper S, Möller HJ, Langer M, Barlage U, Rao ML.

J Pharmacol Exp Ther. 1999 Nov;291(2):547-54.

PMID:
10525070
27.

No association between an intronic polymorphism in the presenilin-1 gene and Alzheimer disease in a German population.

Bagli M, Papassotiropoulos A, Schwab SG, Jessen F, Rao ML, Maier W, Heun R.

J Neurol Sci. 1999 Aug 1;167(1):34-6.

PMID:
10500259
28.

Early-onset and late-onset depression are independent of the genetic polymorphism of apolipoprotein E.

Papassotiropoulos A, Bagli M, Jessen F, Rao ML, Schwab SG, Heun R.

Dement Geriatr Cogn Disord. 1999 Jul-Aug;10(4):258-61.

PMID:
10364642
29.

Persistently increased density of serotonin transporters in the frontal cortex of rats treated with fluoxetine during early juvenile life.

Wegerer V, Moll GH, Bagli M, Rothenberger A, Rüther E, Huether G.

J Child Adolesc Psychopharmacol. 1999;9(1):13-24; discussion 25-6.

PMID:
10357514
30.

[A self-rating scale for adverse drug effects and its application in a study of antidepressants].

Dreher J, Kolbinger M, Rodríguez de la Torre B, Bagli M, Malevanyi J, Rao ML.

Fortschr Neurol Psychiatr. 1999 Apr;67(4):163-74. German.

PMID:
10327312
31.

A genetic variation of the inflammatory cytokine interleukin-6 delays the initial onset and reduces the risk for sporadic Alzheimer's disease.

Papassotiropoulos A, Bagli M, Jessen F, Bayer TA, Maier W, Rao ML, Heun R.

Ann Neurol. 1999 May;45(5):666-8.

PMID:
10319892
32.

Genetic polymorphism of cathepsin D is strongly associated with the risk for developing sporadic Alzheimer's disease.

Papassotiropoulos A, Bagli M, Feder O, Jessen F, Maier W, Rao ML, Ludwig M, Schwab SG, Heun R.

Neurosci Lett. 1999 Mar 12;262(3):171-4.

PMID:
10218883
33.

Serotonin syndrome after lithium add-on medication to paroxetine.

Sobanski T, Bagli M, Laux G, Rao ML.

Pharmacopsychiatry. 1997 May;30(3):106-7.

PMID:
9211572
34.
35.

Pharmacokinetics of chlorprothixene after single intravenous and oral administration of three galenic preparations.

Bagli M, Rao ML, Höflich G, Kasper S, Langer M, Barlage U, Beneke M, Süverkrüp R, Möller HJ.

Arzneimittelforschung. 1996 Mar;46(3):247-50.

PMID:
8901143
36.

Bioequivalence and absolute bioavailability of oblong and coated levomepromazine tablets in CYP2D6 phenotyped subjects.

Bagli M, Höflich G, Rao ML, Langer M, Baumann P, Kolbinger M, Barlage U, Kasper S, Möller HJ.

Int J Clin Pharmacol Ther. 1995 Dec;33(12):646-52.

PMID:
8963481

Supplemental Content

Support Center